Biotechnology
The Biotechnology industry has a total of 613 stocks, with a combined market cap of $1.08 trillion and total revenue of $105.59 billion.
Market Cap
1.08T
Revenue
105.59B
Profits
-42.95B
PE Ratio
n/a
Profit Margin
-40.68%
Dividend Yield
0.04%
613 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 110.20B | 0.07% | 567,468 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 74.08B | 2.51% | 740,313 | 14.25B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 61.57B | 1.20% | 417,596 | 3.21B |
| 4 | ARGX | argenx SE | 56.25B | -0.78% | 252,636 | 3.68B |
| 5 | INSM | Insmed Incorporated | 43.19B | 2.59% | 1,390,801 | 447.02M |
| 6 | ONC | BeOne Medicines AG | 40.35B | -3.19% | 277,226 | 5.00B |
| 7 | BNTX | BioNTech SE | 24.72B | 0.11% | 671,348 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 22.78B | 0.79% | 1,505,357 | 2.35B |
| 9 | INCY | Incyte Corporation | 20.58B | 0.64% | 1,891,064 | 4.81B |
| 10 | GMAB | Genmab A/S | 18.28B | -0.66% | 1,629,791 | 3.85B |
| 11 | ROIV | Roivant Sciences Ltd. | 14.35B | 0.34% | 2,874,365 | 20.33M |
| 12 | RVMD | Revolution Medicines, Inc. | 13.59B | 1.71% | 1,611,212 | - |
| 13 | ASND | Ascendis Pharma A/S | 13.36B | 0.96% | 281,623 | 758.59M |
| 14 | BBIO | BridgeBio Pharma, Inc. | 12.70B | -1.49% | 1,349,769 | 353.78M |
| 15 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.69B | 0.97% | 266,486 | 740.64M |
| 16 | SMMT | Summit Therapeutics Inc. | 12.52B | -0.77% | 2,029,735 | - |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 11.98B | 0.96% | 1,027,342 | 966.96M |
| 18 | EXEL | Exelixis, Inc. | 11.43B | 0.09% | 1,113,575 | 2.29B |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 11.02B | 6.59% | 2,961,046 | 4.16B |
| 20 | RNA | Avidity Biosciences, Inc. | 10.63B | -0.20% | 2,336,855 | 20.87M |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.41B | -0.48% | 1,172,649 | 3.09B |
| 22 | MRNA | Moderna, Inc. | 9.73B | 0.61% | 5,940,895 | 2.23B |
| 23 | TECH | Bio-Techne Corporation | 9.13B | -0.02% | 938,119 | 1.22B |
| 24 | ABVX | ABIVAX Société Anonyme | 8.64B | 0.02% | 906,519 | 7.07M |
| 25 | HALO | Halozyme Therapeutics, Inc. | 8.25B | -0.60% | 828,792 | 1.24B |
| 26 | CYTK | Cytokinetics, Incorporated | 8.12B | -0.78% | 636,055 | 87.21M |
| 27 | CORT | Corcept Therapeutics Incorporated | 7.92B | 0.17% | 208,681 | 741.17M |
| 28 | NUVL | Nuvalent, Inc. | 7.67B | -2.37% | 807,980 | - |
| 29 | AXSM | Axsome Therapeutics, Inc. | 7.46B | 1.72% | 516,594 | 561.26M |
| 30 | MRUS | Merus N.V. | 7.27B | -0.08% | 1,465,999 | 56.61M |
| 31 | CDTX | Cidara Therapeutics, Inc. | 6.87B | 0.28% | 1,800,405 | 302.00K |
| 32 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.74B | 0.31% | 457,987 | 174.33M |
| 33 | CAI | Caris Life Sciences, Inc. | 6.66B | -0.42% | 857,868 | 649.06M |
| 34 | PCVX | Vaxcyte, Inc. | 6.45B | 1.94% | 1,612,705 | - |
| 35 | PTCT | PTC Therapeutics, Inc. | 6.17B | 1.63% | 629,806 | 1.78B |
| 36 | KRYS | Krystal Biotech, Inc. | 5.95B | -1.46% | 78,244 | 373.16M |
| 37 | ARWR | Arrowhead Pharmaceuticals, Inc. | 5.78B | 4.11% | 2,193,567 | 572.98M |
| 38 | LEGN | Legend Biotech Corporation | 5.46B | -0.47% | 1,071,055 | 909.05M |
| 39 | PTGX | Protagonist Therapeutics, Inc. | 5.30B | -0.07% | 419,509 | 209.22M |
| 40 | ACLX | Arcellx, Inc. | 5.20B | -0.41% | 478,592 | 35.90M |
| 41 | CRSP | CRISPR Therapeutics AG | 5.16B | -2.06% | 1,717,346 | 38.34M |
| 42 | COGT | Cogent Biosciences, Inc. | 5.16B | 0.50% | 1,458,484 | - |
| 43 | PRAX | Praxis Precision Medicines, Inc. | 4.78B | -3.22% | 455,265 | 7.46M |
| 44 | KYMR | Kymera Therapeutics, Inc. | 4.67B | 1.25% | 212,448 | 43.74M |
| 45 | TGTX | TG Therapeutics, Inc. | 4.57B | 1.76% | 961,798 | 531.90M |
| 46 | AKRO | Akero Therapeutics, Inc. | 4.47B | -0.01% | 504,720 | - |
| 47 | NAMS | NewAmsterdam Pharma Company N.V. | 4.45B | 1.82% | 589,431 | 35.24M |
| 48 | APGE | Apogee Therapeutics, Inc. | 4.34B | -0.74% | 255,614 | - |
| 49 | VKTX | Viking Therapeutics, Inc. | 4.29B | -0.63% | 2,628,808 | - |
| 50 | CELC | Celcuity Inc. | 4.26B | -0.27% | 1,018,283 | - |
| 51 | BLTE | Belite Bio, Inc | 4.25B | 4.29% | 111,720 | - |
| 52 | CNTA | Centessa Pharmaceuticals plc | 4.14B | 3.81% | 1,368,718 | 15.00M |
| 53 | IMVT | Immunovant, Inc. | 4.13B | -3.13% | 682,713 | - |
| 54 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.10B | -0.74% | 567,457 | 1.54M |
| 55 | ACAD | ACADIA Pharmaceuticals Inc. | 4.03B | -0.75% | 951,255 | 1.05B |
| 56 | SRRK | Scholar Rock Holding Corporation | 4.02B | 8.09% | 2,467,323 | - |
| 57 | MIRM | Mirum Pharmaceuticals, Inc. | 3.72B | 0.12% | 236,589 | 471.79M |
| 58 | ADMA | ADMA Biologics, Inc. | 3.71B | 1.04% | 1,043,146 | 488.56M |
| 59 | MLYS | Mineralys Therapeutics, Inc. | 3.50B | -0.14% | 560,750 | - |
| 60 | CGON | CG Oncology, Inc. | 3.48B | 4.63% | 663,705 | 2.17M |
| 61 | ARQT | Arcutis Biotherapeutics, Inc. | 3.41B | 6.23% | 2,168,826 | 317.93M |
| 62 | IRON | Disc Medicine, Inc. | 3.39B | 0.26% | 145,156 | - |
| 63 | TARS | Tarsus Pharmaceuticals, Inc. | 3.32B | 5.37% | 415,698 | 366.10M |
| 64 | TVTX | Travere Therapeutics, Inc. | 3.26B | 2.91% | 1,015,751 | 435.83M |
| 65 | RARE | Ultragenyx Pharmaceutical Inc. | 3.18B | 1.35% | 520,771 | 630.60M |
| 66 | XENE | Xenon Pharmaceuticals Inc. | 3.16B | 0.66% | 468,431 | 7.50M |
| 67 | TLX | Telix Pharmaceuticals Limited | 3.09B | -0.11% | 77,613 | 664.23M |
| 68 | DYN | Dyne Therapeutics, Inc. | 3.01B | 4.00% | 1,465,575 | - |
| 69 | AAPG | Ascentage Pharma Group International | 2.99B | -2.34% | 14,257 | 54.52M |
| 70 | IDYA | IDEAYA Biosciences, Inc. | 2.97B | 1.47% | 452,333 | 214.83M |
| 71 | FOLD | Amicus Therapeutics, Inc. | 2.96B | 1.91% | 2,215,466 | 598.70M |
| 72 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.77B | -0.09% | 428,669 | 578.20M |
| 73 | VRDN | Viridian Therapeutics, Inc. | 2.75B | -0.76% | 617,542 | 70.79M |
| 74 | LQDA | Liquidia Corporation | 2.68B | 8.49% | 3,619,107 | 69.22M |
| 75 | AGIO | Agios Pharmaceuticals, Inc. | 2.65B | 0.66% | 373,977 | 44.79M |
| 76 | SLNO | Soleno Therapeutics, Inc. | 2.64B | 3.85% | 848,160 | 98.68M |
| 77 | DNLI | Denali Therapeutics Inc. | 2.56B | 0.63% | 514,839 | - |
| 78 | OCUL | Ocular Therapeutix, Inc. | 2.54B | 0.17% | 1,838,505 | 55.78M |
| 79 | APLS | Apellis Pharmaceuticals, Inc. | 2.53B | -0.40% | 1,057,175 | 1.02B |
| 80 | TERN | Terns Pharmaceuticals, Inc. | 2.46B | 6.81% | 4,528,490 | - |
| 81 | EWTX | Edgewise Therapeutics, Inc. | 2.35B | -0.31% | 614,300 | - |
| 82 | ZLAB | Zai Lab Limited | 2.26B | -2.10% | 282,796 | 441.63M |
| 83 | BEAM | Beam Therapeutics Inc. | 2.19B | 0.73% | 1,197,962 | 55.70M |
| 84 | RCUS | Arcus Biosciences, Inc. | 2.19B | 1.38% | 829,836 | 240.00M |
| 85 | RXRX | Recursion Pharmaceuticals, Inc. | 2.18B | 1.70% | 22,289,517 | 43.69M |
| 86 | GPCR | Structure Therapeutics Inc. | 2.13B | -6.36% | 1,292,768 | - |
| 87 | ADPT | Adaptive Biotechnologies Corporation | 2.10B | 0.51% | 1,302,944 | 252.75M |
| 88 | IBRX | ImmunityBio, Inc. | 2.09B | 4.68% | 8,018,360 | 82.56M |
| 89 | AUPH | Aurinia Pharmaceuticals Inc. | 2.04B | - | 952,742 | 265.81M |
| 90 | ZBIO | Zenas BioPharma, Inc. | 2.02B | 4.78% | 223,025 | 15.00M |
| 91 | GLPG | Galapagos NV | 2.00B | -0.62% | 103,813 | 336.64M |
| 92 | VCEL | Vericel Corporation | 1.97B | -1.37% | 189,514 | 258.72M |
| 93 | HRMY | Harmony Biosciences Holdings, Inc. | 1.95B | -0.24% | 639,956 | 825.94M |
| 94 | IMCR | Immunocore Holdings plc | 1.91B | 3.50% | 109,879 | 379.59M |
| 95 | MESO | Mesoblast Limited | 1.90B | -1.13% | 75,745 | 17.20M |
| 96 | QURE | uniQure N.V. | 1.90B | 0.56% | 1,351,754 | 15.75M |
| 97 | SYRE | Spyre Therapeutics, Inc. | 1.87B | -0.82% | 292,761 | - |
| 98 | VERA | Vera Therapeutics, Inc. | 1.85B | -1.93% | 792,754 | - |
| 99 | SRPT | Sarepta Therapeutics, Inc. | 1.82B | -0.74% | 2,418,592 | 2.41B |
| 100 | JANX | Janux Therapeutics, Inc. | 1.76B | 1.92% | 444,932 | 10.00M |
| 101 | PHVS | Pharvaris N.V. | 1.75B | -2.85% | 128,007 | - |
| 102 | ZYME | Zymeworks Inc. | 1.75B | -2.22% | 2,689,883 | 134.48M |
| 103 | DNTH | Dianthus Therapeutics, Inc. | 1.74B | -1.74% | 381,804 | 3.08M |
| 104 | SION | Sionna Therapeutics, Inc. | 1.74B | -2.30% | 192,926 | - |
| 105 | CLDX | Celldex Therapeutics, Inc. | 1.72B | -0.42% | 295,031 | 2.60M |
| 106 | PGEN | Precigen, Inc. | 1.71B | -1.43% | 2,957,738 | 6.31M |
| 107 | NUVB | Nuvation Bio Inc. | 1.66B | 3.85% | 4,408,238 | 26.75M |
| 108 | STOK | Stoke Therapeutics, Inc. | 1.65B | 7.35% | 719,433 | 205.63M |
| 109 | IMNM | Immunome, Inc. | 1.64B | -1.27% | 700,652 | 9.68M |
| 110 | MAZE | Maze Therapeutics, Inc. | 1.64B | 1.40% | 297,072 | 2.50M |
| 111 | INVA | Innoviva, Inc. | 1.63B | -0.96% | 315,057 | 388.52M |
| 112 | MNKD | MannKind Corporation | 1.56B | 1.71% | 2,391,973 | 313.79M |
| 113 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.53B | -0.25% | 776,067 | -665.00K |
| 114 | SNDX | Syndax Pharmaceuticals, Inc. | 1.50B | 0.41% | 944,817 | 111.30M |
| 115 | TRVI | Trevi Therapeutics, Inc. | 1.47B | 0.79% | 610,452 | - |
| 116 | OLMA | Olema Pharmaceuticals, Inc. | 1.43B | 144.72% | 79,545,957 | - |
| 117 | ARDX | Ardelyx, Inc. | 1.42B | -1.35% | 1,718,090 | 398.23M |
| 118 | UPB | Upstream Bio, Inc. | 1.38B | -0.33% | 403,952 | 2.80M |
| 119 | ORKA | Oruka Therapeutics, Inc. | 1.34B | -2.23% | 246,736 | - |
| 120 | ELVN | Enliven Therapeutics, Inc. | 1.31B | 1.72% | 415,473 | - |
| 121 | NRIX | Nurix Therapeutics, Inc. | 1.27B | -1.95% | 435,404 | 83.69M |
| 122 | BHVN | Biohaven Ltd. | 1.25B | 14.03% | 4,923,381 | - |
| 123 | IMTX | Immatics N.V. | 1.23B | 7.18% | 418,974 | 99.45M |
| 124 | NKTR | Nektar Therapeutics | 1.21B | -0.08% | 300,726 | 62.60M |
| 125 | RAPP | Rapport Therapeutics, Inc. | 1.21B | 0.84% | 113,089 | - |
| 126 | XERS | Xeris Biopharma Holdings, Inc. | 1.19B | -1.52% | 1,303,466 | 266.14M |
| 127 | WVE | Wave Life Sciences Ltd. | 1.18B | -1.19% | 1,570,572 | 109.23M |
| 128 | CVAC | CureVac N.V. | 1.18B | -0.66% | 567,167 | 599.54M |
| 129 | EYPT | EyePoint Pharmaceuticals, Inc. | 1.18B | 8.37% | 1,499,561 | 42.34M |
| 130 | MBX | MBX Biosciences, Inc. | 1.18B | 2.46% | 175,809 | - |
| 131 | XNCR | Xencor, Inc. | 1.17B | 5.12% | 650,692 | 150.13M |
| 132 | ORIC | ORIC Pharmaceuticals, Inc. | 1.17B | -0.58% | 633,708 | - |
| 133 | TSHA | Taysha Gene Therapies, Inc. | 1.15B | 2.31% | 1,901,665 | 6.31M |
| 134 | MNMD | Mind Medicine (MindMed) Inc. | 1.14B | 2.03% | 744,957 | - |
| 135 | RLAY | Relay Therapeutics, Inc. | 1.13B | -1.66% | 1,135,046 | 8.36M |
| 136 | INBX | Inhibrx Biosciences, Inc. | 1.13B | 0.22% | 95,742 | 1.40M |
| 137 | URGN | UroGen Pharma Ltd. | 1.12B | 0.59% | 815,443 | 96.52M |
| 138 | PHAR | Pharming Group N.V. | 1.11B | -2.38% | 7,296 | 362.27M |
| 139 | ABCL | AbCellera Biologics Inc. | 1.10B | 2.36% | 2,344,261 | 35.33M |
| 140 | TNGX | Tango Therapeutics, Inc. | 1.08B | 0.88% | 1,072,342 | 66.50M |
| 141 | NVAX | Novavax, Inc. | 1.07B | -3.01% | 3,090,318 | 1.06B |
| 142 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 1.07B | -1.82% | 109,020 | - |
| 143 | PHAT | Phathom Pharmaceuticals, Inc. | 1.06B | 5.27% | 847,326 | 147.19M |
| 144 | KOD | Kodiak Sciences Inc. | 1.04B | -0.96% | 1,220,738 | - |
| 145 | NBTX | Nanobiotix S.A. | 1.03B | 0.27% | 44,580 | 11.93M |
| 146 | ANAB | AnaptysBio, Inc. | 1.02B | 5.92% | 223,396 | 169.47M |
| 147 | SVRA | Savara Inc. | 1.02B | 0.24% | 548,500 | - |
| 148 | OCS | Oculis Holding AG | 1.01B | 0.60% | 62,907 | 992.00K |
| 149 | MDXG | MiMedx Group, Inc. | 995.25M | -5.35% | 570,921 | 393.44M |
| 150 | NTLA | Intellia Therapeutics, Inc. | 986.87M | 0.47% | 3,395,733 | 57.53M |
| 151 | MLTX | MoonLake Immunotherapeutics | 984.96M | 6.24% | 2,556,110 | - |
| 152 | IOVA | Iovance Biotherapeutics, Inc. | 984.48M | 2.48% | 8,752,552 | 250.43M |
| 153 | KURA | Kura Oncology, Inc. | 981.56M | 3.96% | 1,171,147 | 104.03M |
| 154 | SEPN | Septerna, Inc. | 971.60M | 0.28% | 202,915 | 22.05M |
| 155 | PVLA | Palvella Therapeutics, Inc. | 970.59M | 0.44% | 159,375 | - |
| 156 | SANA | Sana Biotechnology, Inc. | 950.93M | -1.92% | 2,607,216 | - |
| 157 | RZLT | Rezolute, Inc. | 941.18M | -0.68% | 633,720 | - |
| 158 | MRVI | Maravai LifeSciences Holdings, Inc. | 933.33M | 9.28% | 2,513,993 | 192.44M |
| 159 | FTRE | Fortrea Holdings Inc. | 926.77M | 2.45% | 563,367 | 2.76B |
| 160 | TBPH | Theravance Biopharma, Inc. | 926.29M | 1.33% | 322,692 | 80.33M |
| 161 | DAWN | Day One Biopharmaceuticals, Inc. | 890.20M | -1.92% | 896,402 | 133.67M |
| 162 | CMPX | Compass Therapeutics, Inc. | 885.75M | 1.84% | 1,426,391 | 850.00K |
| 163 | GLUE | Monte Rosa Therapeutics, Inc. | 867.37M | -2.13% | 394,952 | 181.54M |
| 164 | ABUS | Arbutus Biopharma Corporation | 858.73M | -1.65% | 586,424 | 14.61M |
| 165 | BCAX | Bicara Therapeutics Inc. | 854.60M | 3.65% | 220,298 | - |
| 166 | GHRS | GH Research PLC | 853.52M | -2.41% | 216,629 | - |
| 167 | ATAI | Atai Beckley N.V. | 850.92M | 0.25% | 3,722,416 | 3.02M |
| 168 | TYRA | Tyra Biosciences, Inc. | 847.02M | -0.19% | 244,629 | - |
| 169 | ARVN | Arvinas, Inc. | 841.34M | 18.66% | 14,103,207 | 312.30M |
| 170 | LENZ | LENZ Therapeutics, Inc. | 838.57M | 4.28% | 502,289 | 17.50M |
| 171 | RIGL | Rigel Pharmaceuticals, Inc. | 835.87M | 8.33% | 635,302 | 282.08M |
| 172 | AVBP | ArriVent BioPharma, Inc. | 831.82M | -2.61% | 91,937 | - |
| 173 | ERAS | Erasca, Inc. | 800.07M | -1.74% | 815,326 | - |
| 174 | CRMD | CorMedix Inc. | 798.92M | 1.60% | 1,317,106 | 214.30M |
| 175 | RAPT | RAPT Therapeutics, Inc. | 774.52M | -2.44% | 190,038 | - |
| 176 | VIR | Vir Biotechnology, Inc. | 769.36M | 0.73% | 546,720 | 16.86M |
| 177 | VALN | Valneva SE | 762.05M | 0.79% | 8,056 | 230.57M |
| 178 | KALV | KalVista Pharmaceuticals, Inc. | 726.35M | -3.30% | 835,605 | 1.43M |
| 179 | VSTM | Verastem, Inc. | 720.11M | 1.97% | 1,493,495 | 13.38M |
| 180 | ATXS | Astria Therapeutics, Inc. | 714.13M | -0.48% | 477,391 | 706.00K |
| 181 | GOSS | Gossamer Bio, Inc. | 710.57M | 2.68% | 1,739,262 | 44.05M |
| 182 | YDES | YD Bio Limited | 710.23M | -5.87% | 45,462 | 510.36K |
| 183 | VTYX | Ventyx Biosciences, Inc. | 706.45M | 4.21% | 848,160 | - |
| 184 | GERN | Geron Corporation | 705.38M | -2.21% | 3,813,040 | 183.40M |
| 185 | SPRY | ARS Pharmaceuticals, Inc. | 698.86M | -3.42% | 1,649,958 | 142.77M |
| 186 | PROK | ProKidney Corp. | 694.93M | 2.67% | 1,383,897 | 744.00K |
| 187 | GYRE | Gyre Therapeutics, Inc. | 694.40M | -4.74% | 41,802 | 107.27M |
| 188 | LXEO | Lexeo Therapeutics, Inc. | 680.97M | -1.58% | 567,743 | - |
| 189 | REPL | Replimune Group, Inc. | 680.89M | -1.03% | 1,010,359 | - |
| 190 | CRVS | Corvus Pharmaceuticals, Inc. | 679.61M | 2.13% | 444,663 | - |
| 191 | ALMS | Alumis Inc. | 651.94M | 12.02% | 965,034 | 22.12M |
| 192 | MPLT | MapLight Therapeutics, Inc. | 649.08M | 8.64% | 84,483 | - |
| 193 | PRME | Prime Medicine, Inc. | 636.45M | -5.89% | 3,572,586 | 5.98M |
| 194 | MGTX | MeiraGTx Holdings plc | 623.00M | -1.78% | 351,151 | 27.42M |
| 195 | OMER | Omeros Corporation | 616.83M | -4.19% | 1,766,616 | - |
| 196 | CTMX | CytomX Therapeutics, Inc. | 614.20M | 2.11% | 2,315,772 | 113.63M |
| 197 | IVVD | Invivyd, Inc. | 596.79M | -9.86% | 14,535,766 | 50.04M |
| 198 | EVMN | Evommune, Inc. | 595.84M | 1.85% | 25,141 | 3.00M |
| 199 | FDMT | 4D Molecular Therapeutics, Inc. | 594.78M | -4.93% | 690,352 | 120.00K |
| 200 | RGNX | REGENXBIO Inc. | 577.10M | 2.33% | 369,077 | 161.32M |
| 201 | ASMB | Assembly Biosciences, Inc. | 571.32M | -0.58% | 70,760 | 37.19M |
| 202 | IVA | Inventiva S.A. | 569.71M | 3.20% | 229,553 | 19.93M |
| 203 | JBIO | Jade Biosciences, Inc. | 567.00M | -2.10% | 86,221 | - |
| 204 | NAGE | Niagen Bioscience, Inc. | 560.62M | 1.01% | 403,403 | 124.71M |
| 205 | PRTA | Prothena Corporation plc | 557.41M | 1.02% | 195,789 | 11.79M |
| 206 | ZVRA | Zevra Therapeutics, Inc. | 552.28M | 6.86% | 1,118,714 | 84.39M |
| 207 | MNPR | Monopar Therapeutics Inc. | 546.64M | 7.03% | 129,484 | - |
| 208 | LXRX | Lexicon Pharmaceuticals, Inc. | 536.01M | 1.03% | 1,002,602 | 70.86M |
| 209 | NBP | NovaBridge Biosciences | 531.38M | 5.49% | 267,469 | - |
| 210 | FULC | Fulcrum Therapeutics, Inc. | 529.28M | 1.35% | 297,216 | 80.00M |
| 211 | KROS | Keros Therapeutics, Inc. | 528.59M | -0.12% | 680,798 | 246.72M |
| 212 | CGEM | Cullinan Therapeutics, Inc. | 508.06M | -1.94% | 383,421 | - |
| 213 | ADCT | ADC Therapeutics SA | 494.89M | 0.63% | 483,619 | 75.21M |
| 214 | ALT | Altimmune, Inc. | 483.63M | 10.62% | 2,865,119 | 20.00K |
| 215 | DBVT | DBV Technologies S.A. | 469.32M | 3.56% | 16,439 | 5.50M |
| 216 | ENGN | enGene Holdings Inc. | 468.84M | -9.93% | 493,589 | - |
| 217 | OPT | Opthea Limited | 466.57M | 7.23% | 3,025 | 146.00K |
| 218 | BNTC | Benitec Biopharma Inc. | 462.22M | 0.89% | 152,126 | - |
| 219 | IMRX | Immuneering Corporation | 462.00M | 3.40% | 827,119 | - |
| 220 | ANNX | Annexon, Inc. | 458.07M | 4.80% | 2,164,426 | - |
| 221 | DRUG | Bright Minds Biosciences Inc. | 449.50M | 0.38% | 169,706 | - |
| 222 | DNA | Ginkgo Bioworks Holdings, Inc. | 447.02M | 1.09% | 827,840 | 180.61M |
| 223 | NMRA | Neumora Therapeutics, Inc. | 444.46M | 2.70% | 542,704 | - |
| 224 | BCYC | Bicycle Therapeutics plc | 443.26M | -1.08% | 243,926 | 28.34M |
| 225 | DSGN | Design Therapeutics, Inc. | 432.35M | 2.15% | 328,375 | - |
| 226 | ABSI | Absci Corporation | 430.06M | - | 3,295,836 | 2.82M |
| 227 | LCTX | Lineage Cell Therapeutics, Inc. | 426.50M | 1.15% | 1,006,688 | 10.82M |
| 228 | XOMA | XOMA Royalty Corporation | 410.75M | 3.56% | 82,129 | 47.11M |
| 229 | PEPG | PepGen Inc. | 404.93M | 10.09% | 767,723 | - |
| 230 | GALT | Galectin Therapeutics Inc. | 401.71M | 3.83% | 330,679 | - |
| 231 | LBRX | LB Pharmaceuticals Inc | 399.98M | -7.27% | 81,262 | - |
| 232 | ANRO | Alto Neuroscience, Inc. | 397.76M | 6.45% | 317,023 | - |
| 233 | LYEL | Lyell Immunopharma, Inc. | 381.15M | 3.12% | 18,072 | 41.00K |
| 234 | PRTC | PureTech Health plc | 377.83M | 1.19% | 101 | 6.39M |
| 235 | VTVT | vTv Therapeutics Inc. | 374.75M | 0.17% | 13,079 | 17.00K |
| 236 | DMAC | DiaMedica Therapeutics Inc. | 361.42M | 8.27% | 550,722 | - |
| 237 | OCGN | Ocugen, Inc. | 359.17M | -0.86% | 2,390,488 | 5.37M |
| 238 | SLDB | Solid Biosciences Inc. | 356.44M | 5.41% | 1,245,151 | - |
| 239 | ENTA | Enanta Pharmaceuticals, Inc. | 355.16M | -0.62% | 341,478 | 65.32M |
| 240 | AURA | Aura Biosciences, Inc. | 347.36M | -0.55% | 101,646 | - |
| 241 | KYTX | Kyverna Therapeutics, Inc. | 345.99M | 10.34% | 1,385,584 | - |
| 242 | AUTL | Autolus Therapeutics plc | 345.99M | -2.99% | 1,334,892 | 51.13M |
| 243 | NGNE | Neurogene Inc. | 341.09M | -1.96% | 170,098 | 925.00K |
| 244 | EPRX | Eupraxia Pharmaceuticals Inc. | 339.03M | -2.58% | 93,627 | - |
| 245 | TECX | Tectonic Therapeutic, Inc. | 338.58M | -1.58% | 271,088 | - |
| 246 | CTNM | Contineum Therapeutics, Inc. | 335.89M | 3.23% | 134,506 | - |
| 247 | AVTX | Avalo Therapeutics, Inc. | 330.40M | 7.97% | 445,314 | 192.00K |
| 248 | RCKT | Rocket Pharmaceuticals, Inc. | 321.42M | -2.30% | 2,559,691 | - |
| 249 | PALI | Palisade Bio, Inc. | 321.10M | 4.11% | 2,121,638 | - |
| 250 | DRTS | Alpha Tau Medical Ltd. | 320.61M | -1.05% | 15,828 | - |
| 251 | SLN | Silence Therapeutics plc | 318.83M | 0.75% | 128,639 | 25.83M |
| 252 | VNDA | Vanda Pharmaceuticals Inc. | 318.53M | 22.50% | 4,222,355 | 212.07M |
| 253 | XFOR | X4 Pharmaceuticals, Inc. | 314.77M | -1.64% | 401,182 | 33.98M |
| 254 | TRDA | Entrada Therapeutics, Inc. | 314.15M | 3.42% | 139,799 | 61.52M |
| 255 | TENX | Tenax Therapeutics, Inc. | 313.20M | 5.03% | 116,891 | - |
| 256 | CLLS | Cellectis S.A. | 309.95M | 0.24% | 102,455 | 82.55M |
| 257 | RLMD | Relmada Therapeutics, Inc. | 308.00M | 5.79% | 566,596 | - |
| 258 | FBRX | Forte Biosciences, Inc. | 305.83M | 18.36% | 63,955 | - |
| 259 | ACIU | AC Immune SA | 303.76M | -0.97% | 109,372 | 5.48M |
| 260 | AVXL | Anavex Life Sciences Corp. | 303.21M | -1.40% | 1,909,273 | - |
| 261 | ALDX | Aldeyra Therapeutics, Inc. | 297.20M | -0.20% | 398,144 | - |
| 262 | PYXS | Pyxis Oncology, Inc. | 295.76M | 2.15% | 412,059 | 2.82M |
| 263 | LRMR | Larimar Therapeutics, Inc. | 294.00M | -2.69% | 1,002,009 | - |
| 264 | MREO | Mereo BioPharma Group plc | 292.80M | 3.95% | 1,013,325 | 500.00K |
| 265 | ALLO | Allogene Therapeutics, Inc. | 292.15M | 5.69% | 2,472,713 | 22.00K |
| 266 | FENC | Fennec Pharmaceuticals Inc. | 282.27M | -1.60% | 133,273 | 38.79M |
| 267 | NAUT | Nautilus Biotechnology, Inc. | 277.87M | 15.79% | 532,161 | - |
| 268 | FHTX | Foghorn Therapeutics Inc. | 271.96M | -0.02% | 132,517 | 24.52M |
| 269 | ACRS | Aclaris Therapeutics, Inc. | 269.24M | 1.43% | 524,754 | 15.74M |
| 270 | IMMP | Immutep Limited | 263.05M | -5.95% | 266,432 | 3.31M |
| 271 | TARA | Protara Therapeutics, Inc. | 262.39M | 22.08% | 1,182,035 | - |
| 272 | SGMT | Sagimet Biosciences Inc. | 257.90M | 1.54% | 272,087 | - |
| 273 | CAPR | Capricor Therapeutics, Inc. | 256.48M | -1.41% | 639,276 | 11.13M |
| 274 | CBIO | Crescent Biopharma, Inc. | 255.90M | 0.15% | 48,942 | - |
| 275 | PBYI | Puma Biotechnology, Inc. | 254.48M | 1.81% | 263,833 | 212.00M |
| 276 | CADL | Candel Therapeutics, Inc. | 253.63M | -2.33% | 543,769 | - |
| 277 | ARMP | Armata Pharmaceuticals, Inc. | 252.86M | 3.73% | 80,632 | 5.05M |
| 278 | EDIT | Editas Medicine, Inc. | 251.86M | - | 588,202 | 46.38M |
| 279 | ZURA | Zura Bio Limited | 248.04M | -4.39% | 172,497 | - |
| 280 | MIST | Milestone Pharmaceuticals Inc. | 245.83M | 4.31% | 4,980,277 | - |
| 281 | ABEO | Abeona Therapeutics Inc. | 245.76M | 0.55% | 1,075,100 | 400.00K |
| 282 | CCCC | C4 Therapeutics, Inc. | 242.29M | - | 787,834 | 30.11M |
| 283 | AVIR | Atea Pharmaceuticals, Inc. | 239.46M | 1.49% | 305,074 | - |
| 284 | OBIO | Orchestra BioMed Holdings, Inc. | 238.85M | 2.42% | 313,202 | 2.82M |
| 285 | VYGR | Voyager Therapeutics, Inc. | 237.69M | 4.01% | 290,683 | 31.32M |
| 286 | MDWD | MediWound Ltd. | 236.49M | 0.35% | 16,009 | 19.86M |
| 287 | SLS | SELLAS Life Sciences Group, Inc. | 234.32M | 16.67% | 3,810,267 | - |
| 288 | CABA | Cabaletta Bio, Inc. | 230.07M | - | 1,447,024 | - |
| 289 | ACHV | Achieve Life Sciences, Inc. | 229.78M | -1.90% | 319,352 | - |
| 290 | BDTX | Black Diamond Therapeutics, Inc. | 227.90M | -0.25% | 672,963 | 70.00M |
| 291 | RANI | Rani Therapeutics Holdings, Inc. | 227.83M | -3.35% | 1,391,579 | 1.20M |
| 292 | OABI | OmniAb, Inc. | 224.57M | 2.63% | 661,822 | 21.09M |
| 293 | MCRB | Seres Therapeutics, Inc. | 223.45M | 14.14% | 644,727 | 351.00K |
| 294 | HUMA | Humacyte, Inc. | 221.92M | 4.87% | 3,256,082 | 1.57M |
| 295 | GNFT | Genfit S.A. | 220.50M | -2.17% | 26,047 | 52.99M |
| 296 | PRQR | ProQR Therapeutics N.V. | 219.12M | 1.46% | 269,981 | 18.86M |
| 297 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 212.92M | 7.82% | 349,875 | - |
| 298 | AARD | Aardvark Therapeutics, Inc. | 212.51M | -5.79% | 173,211 | - |
| 299 | TNYA | Tenaya Therapeutics, Inc. | 210.63M | 0.40% | 2,141,380 | - |
| 300 | ETHZ | ETHZilla Corporation | 205.99M | 4.05% | 920,314 | 4.11M |
| 301 | TLSA | Tiziana Life Sciences Ltd | 205.57M | 2.37% | 77,317 | - |
| 302 | HRTX | Heron Therapeutics, Inc. | 199.87M | - | 1,758,304 | 155.10M |
| 303 | RNAC | Cartesian Therapeutics, Inc. | 196.85M | 2.57% | 41,648 | 1.09M |
| 304 | ARCT | Arcturus Therapeutics Holdings Inc. | 192.92M | 0.44% | 552,458 | 97.60M |
| 305 | GNLX | Genelux Corporation | 192.23M | -2.67% | 224,782 | 8.00K |
| 306 | CAMP | Camp4 Therapeutics Corporation | 190.81M | 2.01% | 42,253 | 3.80M |
| 307 | TNXP | Tonix Pharmaceuticals Holding Corp. | 189.37M | -4.31% | 530,418 | 10.30M |
| 308 | VOR | Vor Biopharma Inc. | 187.37M | -8.38% | 832,627 | - |
| 309 | GUTS | Fractyl Health, Inc. | 184.41M | -2.45% | 1,501,581 | 3.00K |
| 310 | CRBU | Caribou Biosciences, Inc. | 177.12M | 0.26% | 1,031,034 | 9.30M |
| 311 | CYBN | Cybin Inc. | 168.52M | 0.49% | 307,320 | - |
| 312 | IPHA | Innate Pharma S.A. | 165.38M | -0.58% | 35,472 | 14.84M |
| 313 | MOLN | Molecular Partners AG | 158.90M | -3.29% | 3,810 | 856.30K |
| 314 | NVCT | Nuvectis Pharma, Inc. | 157.53M | 1.15% | 28,918 | - |
| 315 | PLX | Protalix BioTherapeutics, Inc. | 153.60M | 1.06% | 415,511 | 61.84M |
| 316 | CGEN | Compugen Ltd. | 152.46M | 2.52% | 237,156 | 6.90M |
| 317 | ELTX | Elicio Therapeutics, Inc. | 149.76M | -1.72% | 69,539 | - |
| 318 | CHRS | Coherus Oncology, Inc. | 148.67M | 8.85% | 1,067,531 | 277.73M |
| 319 | CDXS | Codexis, Inc. | 148.13M | 4.46% | 881,394 | 52.93M |
| 320 | IMMX | Immix Biopharma, Inc. | 148.08M | 9.16% | 450,143 | - |
| 321 | SGMO | Sangamo Therapeutics, Inc. | 145.23M | 5.01% | 3,925,202 | 32.88M |
| 322 | AGEN | Agenus Inc. | 144.54M | -1.62% | 347,763 | 106.83M |
| 323 | VTGN | Vistagen Therapeutics, Inc. | 144.51M | 6.56% | 983,247 | 721.00K |
| 324 | ALEC | Alector, Inc. | 142.44M | 5.24% | 1,147,771 | 69.05M |
| 325 | ACTU | Actuate Therapeutics, Inc. | 141.32M | 2.70% | 14,647 | - |
| 326 | SPRO | Spero Therapeutics, Inc. | 139.28M | 1.85% | 239,167 | 40.55M |
| 327 | MRSN | Mersana Therapeutics, Inc. | 138.99M | 0.47% | 58,386 | 33.18M |
| 328 | NTHI | NeOnc Technologies Holdings, Inc. | 138.90M | -8.92% | 38,516 | 59.99K |
| 329 | CNTB | Connect Biopharma Holdings Limited | 138.08M | -0.80% | 1,292,823 | 762.00K |
| 330 | CRDF | Cardiff Oncology, Inc. | 137.75M | -0.73% | 725,802 | 501.00K |
| 331 | SAVA | Cassava Sciences, Inc. | 137.19M | 2.16% | 380,587 | - |
| 332 | ANIX | Anixa Biosciences, Inc. | 136.28M | -1.43% | 94,740 | - |
| 333 | NBY | NovaBay Pharmaceuticals, Inc. | 136.09M | -0.92% | 68,394 | 10.30M |
| 334 | PRLD | Prelude Therapeutics Incorporated | 135.96M | - | 453,087 | 10.50M |
| 335 | CGTX | Cognition Therapeutics, Inc. | 135.94M | 1.32% | 520,841 | - |
| 336 | CLYM | Climb Bio, Inc. | 132.96M | 3.72% | 251,165 | - |
| 337 | INO | Inovio Pharmaceuticals, Inc. | 131.91M | -3.03% | 903,978 | 182.34K |
| 338 | NKTX | Nkarta, Inc. | 129.63M | 0.83% | 435,668 | - |
| 339 | IRD | Opus Genetics, Inc. | 128.27M | 6.90% | 302,953 | 14.63M |
| 340 | EXOZ | eXoZymes, Inc. | 127.91M | 2.21% | 2,549 | -700.00 |
| 341 | STTK | Shattuck Labs, Inc. | 127.83M | 2.02% | 48,591 | 1.00M |
| 342 | COYA | Coya Therapeutics, Inc. | 127.64M | 4.27% | 117,731 | 3.99M |
| 343 | SPRB | Spruce Biosciences, Inc. | 124.72M | 7.06% | 154,826 | 697.00K |
| 344 | ACOG | Alpha Cognition Inc. | 123.84M | 0.42% | 98,104 | 7.43M |
| 345 | DTIL | Precision BioSciences, Inc. | 123.61M | -0.10% | 83,177 | 698.00K |
| 346 | UNCY | Unicycive Therapeutics, Inc. | 123.15M | -0.69% | 301,230 | - |
| 347 | ENTX | Entera Bio Ltd. | 122.83M | 0.37% | 33,483 | 124.00K |
| 348 | IKT | Inhibikase Therapeutics, Inc. | 119.53M | 4.61% | 12,680 | 1.00 |
| 349 | ELDN | Eledon Pharmaceuticals, Inc. | 118.74M | -2.47% | 1,889,828 | - |
| 350 | FATE | Fate Therapeutics, Inc. | 117.66M | 4.83% | 748,065 | 7.14M |
| 351 | KLRS | Kalaris Therapeutics, Inc. | 116.14M | 14.58% | 132,552 | - |
| 352 | GLSI | Greenwich LifeSciences, Inc. | 114.16M | 0.12% | 26,666 | - |
| 353 | SRZN | Surrozen, Inc. | 111.94M | 2.07% | 36,239 | 3.60M |
| 354 | ONCY | Oncolytics Biotech Inc. | 110.92M | -0.48% | 479,566 | - |
| 355 | SEER | Seer, Inc. | 109.90M | -1.99% | 133,334 | 16.38M |
| 356 | KPTI | Karyopharm Therapeutics Inc. | 104.10M | 5.44% | 101,877 | 142.53M |
| 357 | WHWK | Whitehawk Therapeutics, Inc. | 103.68M | 3.77% | 132,861 | 14.38M |
| 358 | QNCX | Quince Therapeutics, Inc. | 102.73M | 2.50% | 305,986 | - |
| 359 | ATOS | Atossa Therapeutics, Inc. | 102.38M | 0.97% | 351,239 | - |
| 360 | ABOS | Acumen Pharmaceuticals, Inc. | 102.07M | 6.65% | 119,882 | - |
| 361 | ACET | Adicet Bio, Inc. | 101.87M | 6.17% | 1,079,383 | - |
| 362 | GANX | Gain Therapeutics, Inc. | 101.43M | -0.35% | 840,635 | - |
| 363 | HURA | TuHURA Biosciences, Inc. | 100.21M | 3.99% | 216,890 | - |
| 364 | CNTX | Context Therapeutics Inc. | 100.15M | -5.22% | 126,115 | - |
| 365 | ZNTL | Zentalis Pharmaceuticals, Inc. | 100.07M | 4.92% | 336,730 | 26.87M |
| 366 | MGNX | MacroGenics, Inc. | 99.32M | 3.97% | 553,493 | 127.63M |
| 367 | ORMP | Oramed Pharmaceuticals Inc. | 98.43M | 5.56% | 254,685 | 2.00M |
| 368 | ATRA | Atara Biotherapeutics, Inc. | 97.89M | 3.64% | 41,366 | 151.93M |
| 369 | RPTX | Repare Therapeutics Inc. | 97.52M | 4.13% | 1,607,815 | 11.87M |
| 370 | PLRX | Pliant Therapeutics, Inc. | 97.40M | -3.94% | 1,134,025 | - |
| 371 | VXRT | Vaxart, Inc. | 96.98M | 3.82% | 270,480 | 148.20M |
| 372 | ANVS | Annovis Bio, Inc. | 96.47M | 20.13% | 6,127,921 | - |
| 373 | ANEB | Anebulo Pharmaceuticals, Inc. | 95.32M | 1.31% | 8,170 | - |
| 374 | PTHS | Pelthos Therapeutics Inc. | 95.11M | -6.91% | 8,023 | 7.41M |
| 375 | SLGL | Sol-Gel Technologies Ltd. | 94.66M | -5.62% | 7,296 | 23.93M |
| 376 | ADVM | Adverum Biotechnologies, Inc. | 94.16M | -0.12% | 355,932 | 1.00M |
| 377 | OVID | Ovid Therapeutics Inc. | 94.00M | 1.54% | 1,065,101 | 6.61M |
| 378 | CSBR | Champions Oncology, Inc. | 93.49M | 0.44% | 6,774 | 56.88M |
| 379 | ARTV | Artiva Biotherapeutics, Inc. | 91.55M | 6.27% | 137,233 | 251.00K |
| 380 | ADAG | Adagene Inc. | 88.61M | 3.30% | 34,692 | 103.20K |
| 381 | THAR | Tharimmune, Inc. | 88.47M | -7.91% | 369,285 | - |
| 382 | TIL | Instil Bio, Inc. | 87.96M | 2.04% | 63,265 | - |
| 383 | IFRX | InflaRx N.V. | 87.39M | 4.03% | 787,380 | 73.73K |
| 384 | ALXO | ALX Oncology Holdings Inc. | 86.21M | 1.92% | 221,177 | - |
| 385 | OTLK | Outlook Therapeutics, Inc. | 84.62M | 7.63% | 6,037,698 | 1.51M |
| 386 | TVGN | Tevogen Bio Holdings Inc. | 84.22M | 9.56% | 412,113 | - |
| 387 | VANI | Vivani Medical, Inc. | 83.24M | -4.42% | 228,505 | - |
| 388 | BMEA | Biomea Fusion, Inc. | 83.08M | 1.29% | 742,336 | - |
| 389 | TTRX | Turn Therapeutics Inc. | 82.95M | -15.43% | 335,489 | - |
| 390 | HYFT | MindWalk Holdings Corp. | 82.62M | 4.07% | 167,278 | 18.21M |
| 391 | IMA | ImageneBio, Inc. | 80.84M | -1.43% | 17,642 | 800.00K |
| 392 | FBIO | Fortress Biotech, Inc. | 80.78M | 4.02% | 245,764 | 62.30M |
| 393 | OKYO | OKYO Pharma Limited | 80.49M | -0.23% | 88,689 | - |
| 394 | COEP | Coeptis Therapeutics Holdings, Inc. | 79.54M | 8.91% | 36,897 | 501.00K |
| 395 | BYSI | BeyondSpring Inc. | 79.45M | -3.90% | 7,177 | 1.88M |
| 396 | CRVO | CervoMed Inc. | 76.98M | 1.34% | 76,854 | 6.16M |
| 397 | IMUX | Immunic, Inc. | 76.31M | 5.96% | 1,587,305 | - |
| 398 | ACRV | Acrivon Therapeutics, Inc. | 75.65M | 1.05% | 497,441 | - |
| 399 | STRO | Sutro Biopharma, Inc. | 75.38M | 4.15% | 354,652 | 105.65M |
| 400 | PMVP | PMV Pharmaceuticals, Inc. | 73.39M | -2.46% | 123,056 | - |
| 401 | BCAB | BioAtla, Inc. | 71.93M | 20.10% | 4,162,262 | 11.00M |
| 402 | ESLA | Estrella Immunopharma, Inc. | 71.75M | 2.15% | 169,895 | - |
| 403 | XBIT | XBiotech Inc. | 71.62M | -4.89% | 82,552 | - |
| 404 | LITS | Lite Strategy, Inc. | 71.36M | 2.11% | 361,352 | - |
| 405 | PSTV | Plus Therapeutics, Inc. | 70.78M | 8.35% | 2,428,520 | 5.26M |
| 406 | ATHE | Alterity Therapeutics Limited | 70.67M | -4.85% | 17,330 | 3.57M |
| 407 | MNOV | MediciNova, Inc. | 70.14M | 1.42% | 146,322 | 257.92K |
| 408 | CBUS | Cibus, Inc. | 70.03M | 11.30% | 91,582 | 3.79M |
| 409 | ATYR | aTyr Pharma, Inc. | 69.55M | 4.35% | 3,518,591 | 190.00K |
| 410 | ABVC | ABVC BioPharma, Inc. | 68.59M | 0.34% | 58,500 | 797.92K |
| 411 | MGX | Metagenomi, Inc. | 64.74M | 1.47% | 310,877 | 30.91M |
| 412 | EQ | Equillium, Inc. | 61.89M | -2.86% | 100,867 | 4.39M |
| 413 | NTRB | Nutriband Inc. | 61.88M | -4.19% | 12,885 | 2.58M |
| 414 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 60.62M | 10.02% | 2,763,039 | - |
| 415 | PYPD | PolyPid Ltd. | 59.89M | -0.96% | 38,718 | - |
| 416 | KRRO | Korro Bio, Inc. | 59.23M | 2.28% | 784,423 | 7.37M |
| 417 | ANL | Adlai Nortye Ltd. | 57.93M | - | 7 | 1.94M |
| 418 | OSTX | OS Therapies Incorporated | 56.21M | -1.98% | 150,390 | - |
| 419 | TCRX | TScan Therapeutics, Inc. | 55.70M | 1.19% | 594,031 | 8.42M |
| 420 | NRXP | NRx Pharmaceuticals, Inc. | 53.96M | 7.58% | 388,746 | 242.00K |
| 421 | IOBT | IO Biotech, Inc. | 53.65M | 23.42% | 962,196 | - |
| 422 | CVM | CEL-SCI Corporation | 52.60M | 1.23% | 34,829 | - |
| 423 | INKT | MiNK Therapeutics, Inc. | 52.01M | -4.17% | 44,255 | - |
| 424 | JSPR | Jasper Therapeutics, Inc. | 51.77M | 3.35% | 254,784 | - |
| 425 | ALGS | Aligos Therapeutics, Inc. | 49.47M | 14.53% | 91,705 | 2.65M |
| 426 | TELO | Telomir Pharmaceuticals, Inc. | 48.13M | - | 152,571 | - |
| 427 | GRCE | Grace Therapeutics, Inc. | 47.97M | 3.33% | 38,006 | - |
| 428 | CUE | Cue Biopharma, Inc. | 46.35M | 2.56% | 90,138 | 7.10M |
| 429 | HOWL | Werewolf Therapeutics, Inc. | 46.13M | 3.36% | 351,920 | 1.14M |
| 430 | LVTX | LAVA Therapeutics N.V. | 46.03M | 5.42% | 271,196 | 4.99M |
| 431 | IBO | Impact BioMedical Inc. | 45.47M | -3.21% | 56,175 | 25.00K |
| 432 | KZR | Kezar Life Sciences, Inc. | 45.40M | -0.32% | 23,198 | - |
| 433 | SKYE | Skye Bioscience, Inc. | 44.56M | -0.71% | 119,950 | - |
| 434 | CALC | CalciMedica, Inc. | 44.09M | -2.67% | 5,615 | - |
| 435 | CELU | Celularity Inc. | 44.04M | 8.55% | 33,376 | 40.58M |
| 436 | ATNM | Actinium Pharmaceuticals, Inc. | 43.82M | -3.13% | 162,122 | 90.00K |
| 437 | JUNS | Jupiter Neurosciences, Inc. | 43.54M | -1.57% | 50,342 | - |
| 438 | SNTI | Senti Biosciences, Inc. | 43.43M | 14.49% | 123,835 | - |
| 439 | EVAX | Evaxion A/S | 43.42M | 0.38% | 41,866 | 7.65M |
| 440 | IPSC | Century Therapeutics, Inc. | 42.30M | 1.96% | 561,650 | 113.34M |
| 441 | ICCC | ImmuCell Corporation | 42.06M | -5.30% | 26,941 | 27.77M |
| 442 | TPST | Tempest Therapeutics, Inc. | 41.56M | -0.21% | 20,736 | - |
| 443 | APLT | Applied Therapeutics, Inc. | 41.50M | 1.41% | 27,799,619 | 1.00M |
| 444 | SABS | SAB Biotherapeutics, Inc. | 40.71M | 11.71% | 271,004 | 114.70K |
| 445 | PDSB | PDS Biotechnology Corporation | 40.55M | -1.12% | 341,593 | - |
| 446 | OKUR | OnKure Therapeutics, Inc. | 40.51M | -5.38% | 34,340 | - |
| 447 | VERU | Veru Inc. | 40.45M | -0.79% | 42,467 | 16.89M |
| 448 | BTAI | BioXcel Therapeutics, Inc. | 40.02M | - | 300,886 | 752.00K |
| 449 | SER | Serina Therapeutics, Inc. | 39.83M | -0.97% | 7,786 | 116.00K |
| 450 | APLM | Apollomics, Inc. | 39.79M | -13.57% | 29,780 | 198.00K |
| 451 | RADX | Radiopharm Theranostics Limited | 39.78M | -1.77% | 5,570 | 8.20M |
| 452 | GNTA | Genenta Science S.p.A. | 39.25M | -0.49% | 124,209 | - |
| 453 | INMB | INmune Bio, Inc. | 38.81M | - | 327,553 | 50.00K |
| 454 | XLO | Xilio Therapeutics, Inc. | 38.75M | 3.22% | 231,074 | 31.80M |
| 455 | TVRD | Tvardi Therapeutics, Inc. | 38.74M | 2.48% | 115,651 | - |
| 456 | MAIA | MAIA Biotechnology, Inc. | 37.03M | - | 108,367 | - |
| 457 | LTRN | Lantern Pharma Inc. | 36.91M | -1.79% | 35,340 | - |
| 458 | VRCA | Verrica Pharmaceuticals Inc. | 36.65M | 4.02% | 66,271 | 30.83M |
| 459 | MURA | Mural Oncology plc | 36.21M | 0.48% | 64,861 | - |
| 460 | GBIO | Generation Bio Co. | 35.68M | -1.94% | 33,310 | 15.27M |
| 461 | FGEN | FibroGen, Inc. | 34.79M | -1.15% | 24,946 | 8.30M |
| 462 | HYPD | Hyperion DeFi, Inc. | 34.45M | 16.47% | 319,361 | 345.32K |
| 463 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 33.66M | -7.85% | 643,003 | 1.00M |
| 464 | LIMN | Liminatus Pharma, Inc. | 33.29M | 16.04% | 234,033 | - |
| 465 | KLTO | Klotho Neurosciences, Inc. | 32.96M | 0.88% | 436,802 | - |
| 466 | DYAI | Dyadic International, Inc. | 32.61M | 1.24% | 61,908 | 3.34M |
| 467 | IGC | IGC Pharma, Inc. | 31.51M | 0.76% | 289,739 | 1.11M |
| 468 | PLUR | Pluri Inc. | 30.75M | 3.29% | 10,447 | 1.33M |
| 469 | ANTX | AN2 Therapeutics, Inc. | 30.42M | -0.89% | 50,125 | - |
| 470 | BRNS | Barinthus Biotherapeutics plc | 30.01M | -4.45% | 131,315 | 14.97M |
| 471 | NRSN | NeuroSense Therapeutics Ltd. | 29.55M | 13.69% | 1,583,863 | - |
| 472 | NERV | Minerva Neurosciences, Inc. | 29.30M | -3.90% | 131,551 | - |
| 473 | RNXT | RenovoRx, Inc. | 28.58M | -3.00% | 200,099 | 928.00K |
| 474 | IBIO | iBio, Inc. | 28.33M | 14.55% | 838,328 | 500.00K |
| 475 | NNVC | NanoViricides, Inc. | 28.33M | - | 235,890 | - |
| 476 | QNTM | Quantum BioPharma Ltd. | 27.89M | -6.38% | 70,836 | - |
| 477 | RNTX | Rein Therapeutics Inc. | 27.62M | -2.87% | 105,880 | - |
| 478 | QTTB | Q32 Bio Inc. | 27.57M | -1.31% | 64,538 | - |
| 479 | PASG | Passage Bio, Inc. | 27.02M | -5.35% | 115,315 | - |
| 480 | INTS | Intensity Therapeutics, Inc. | 26.94M | 8.39% | 1,664,261 | - |
| 481 | CLGN | CollPlant Biotechnologies Ltd. | 26.77M | -1.17% | 8,598 | 2.40M |
| 482 | LNAI | Lunai Bioworks Inc. | 26.65M | 11.65% | 570,273 | - |
| 483 | BOLD | Boundless Bio, Inc. | 26.53M | 0.42% | 103,158 | - |
| 484 | GLTO | Galecto, Inc. | 26.31M | -13.26% | 267,803 | - |
| 485 | NXTC | NextCure, Inc. | 26.26M | -3.40% | 42,162 | - |
| 486 | RLYB | Rallybio Corporation | 26.20M | 0.49% | 35,193 | 674.00K |
| 487 | DARE | Daré Bioscience, Inc. | 25.15M | -2.76% | 53,301 | -57.13K |
| 488 | NRXS | NeurAxis, Inc. | 25.14M | 2.16% | 56,891 | 3.36M |
| 489 | CVKD | Cadrenal Therapeutics, Inc. | 24.82M | 2.18% | 13,322 | - |
| 490 | GDTC | CytoMed Therapeutics Limited | 24.70M | 8.08% | 795,543 | 573.19K |
| 491 | LIXT | Lixte Biotechnology Holdings, Inc. | 24.53M | 2.14% | 55,942 | - |
| 492 | XCUR | Exicure, Inc. | 23.77M | 2.75% | 13,946 | 500.00K |
| 493 | ENLV | Enlivex Therapeutics Ltd. | 23.33M | -1.51% | 120,430 | - |
| 494 | LEXX | Lexaria Bioscience Corp. | 22.91M | 1.98% | 113,523 | 615.92K |
| 495 | APVO | Aptevo Therapeutics Inc. | 22.16M | -4.01% | 689,008 | - |
| 496 | MBRX | Moleculin Biotech, Inc. | 20.95M | -0.24% | 837,133 | - |
| 497 | PMN | ProMIS Neurosciences, Inc. | 19.70M | 1.45% | 280,427 | - |
| 498 | SYBX | Synlogic, Inc. | 19.54M | -1.18% | 35,008 | 8.00K |
| 499 | CTXR | Citius Pharmaceuticals, Inc. | 19.40M | 12.29% | 375,879 | - |
| 500 | CING | Cingulate Inc. | 18.95M | 1.50% | 81,440 | - |
| 501 | MTVA | MetaVia Inc. | 18.89M | 3.82% | 123,707 | - |
| 502 | ITRM | Iterum Therapeutics plc | 18.88M | 8.50% | 5,906,883 | 390.00K |
| 503 | AKTX | Akari Therapeutics, Plc | 18.87M | 11.49% | 188,566 | - |
| 504 | HOTH | Hoth Therapeutics, Inc. | 18.62M | 2.56% | 139,893 | - |
| 505 | CASI | CASI Pharmaceuticals, Inc. | 18.59M | 0.84% | 5,278 | 26.85M |
| 506 | LPCN | Lipocine Inc. | 18.38M | 10.33% | 398,189 | 4.32M |
| 507 | ATHA | Athira Pharma, Inc. | 18.26M | 0.65% | 7,747 | - |
| 508 | LSTA | Lisata Therapeutics, Inc. | 17.91M | -2.87% | 11,613 | 1.07M |
| 509 | FBLG | FibroBiologics, Inc. | 17.22M | -0.09% | 518,841 | - |
| 510 | PULM | Pulmatrix, Inc. | 17.21M | -0.77% | 1,126 | 3.00K |
| 511 | PCSA | Processa Pharmaceuticals, Inc. | 16.96M | 9.51% | 1,331,876 | - |
| 512 | CLSD | Clearside Biomedical, Inc. | 16.75M | -4.19% | 20,393 | 3.33M |
| 513 | ALLR | Allarity Therapeutics, Inc. | 16.56M | 1.79% | 217,954 | - |
| 514 | ABP | Abpro Holdings, Inc. | 15.96M | 2.48% | 22,685 | 183.00K |
| 515 | KAPA | Kairos Pharma, Ltd. | 15.89M | -1.29% | 123,895 | - |
| 516 | CANF | Can-Fite BioPharma Ltd. | 15.61M | 13.59% | 347,068,934 | 560.00K |
| 517 | CRIS | Curis, Inc. | 15.58M | -2.03% | 84,067 | 11.65M |
| 518 | TRAW | Traws Pharma, Inc. | 15.46M | 4.33% | 136,153 | 2.85M |
| 519 | BCTX | BriaCell Therapeutics Corp. | 15.31M | -3.97% | 37,968 | - |
| 520 | NCEL | NewcelX Ltd. | 15.22M | -4.02% | 10,750 | - |
| 521 | QNRX | Quoin Pharmaceuticals, Ltd. | 15.14M | 11.35% | 135,364 | - |
| 522 | BLRX | BioLineRx Ltd. | 14.32M | -4.13% | 16,798 | 17.25M |
| 523 | SNGX | Soligenix, Inc. | 13.97M | 2.59% | 155,165 | 2.34K |
| 524 | BCDA | BioCardia, Inc. | 13.84M | 6.93% | 76,704 | 3.00K |
| 525 | LGVN | Longeveron Inc. | 13.75M | -0.71% | 201,022 | 1.44M |
| 526 | CMMB | Chemomab Therapeutics Ltd. | 13.71M | 1.92% | 75,043 | - |
| 527 | DWTX | Dogwood Therapeutics, Inc. | 13.58M | 4.41% | 16,006 | - |
| 528 | MRKR | Marker Therapeutics, Inc. | 13.20M | 6.83% | 397,763 | 4.69M |
| 529 | COCP | Cocrystal Pharma, Inc. | 12.91M | -2.92% | 76,393 | - |
| 530 | VYNE | VYNE Therapeutics Inc. | 12.39M | 0.26% | 956,731 | 524.00K |
| 531 | APM | Aptorum Group Limited | 12.22M | 11.12% | 699,934 | - |
| 532 | EDSA | Edesa Biotech, Inc. | 12.21M | - | 11,730 | - |
| 533 | GOVX | GeoVax Labs, Inc. | 12.08M | -0.78% | 316,679 | 3.35M |
| 534 | NEUP | Neuphoria Therapeutics Inc. | 11.72M | 5.74% | 107,329 | 15.65M |
| 535 | ERNA | Ernexa Therapeutics Inc. | 11.58M | -2.32% | 19,179 | 1,000.00 |
| 536 | IMRN | Immuron Limited | 11.38M | -1.06% | 27,345 | 4.78M |
| 537 | ICU | SeaStar Medical Holding Corporation | 11.19M | 8.28% | 1,914,496 | 881.00K |
| 538 | CELZ | Creative Medical Technology Holdings, Inc. | 11.13M | -1.31% | 41,905 | 6.00K |
| 539 | BRTX | BioRestorative Therapies, Inc. | 11.10M | 0.81% | 12,437 | 383.40K |
| 540 | OSRH | OSR Holdings, Inc. | 10.82M | 3.28% | 210,458 | -90.52K |
| 541 | SNSE | Sensei Biotherapeutics, Inc. | 10.78M | 5.04% | 26,318 | - |
| 542 | BIVI | BioVie Inc. | 10.78M | 1.42% | 20,168 | - |
| 543 | AEON | AEON Biopharma, Inc. | 10.77M | 6.30% | 1,245,333 | - |
| 544 | EVGN | Evogene Ltd. | 10.68M | -1.87% | 25,296 | 9.44M |
| 545 | KZIA | Kazia Therapeutics Limited | 10.57M | -5.29% | 19,473 | 1.20M |
| 546 | ADXN | Addex Therapeutics Ltd | 10.47M | 2.32% | 1,796 | 210.35K |
| 547 | IMNN | Imunon, Inc. | 10.46M | 4.01% | 24,290 | - |
| 548 | PPCB | Propanc Biopharma, Inc. | 10.24M | 5.77% | 54,951 | - |
| 549 | CLRB | Cellectar Biosciences, Inc. | 9.64M | 3.42% | 27,220 | - |
| 550 | ALZN | Alzamend Neuro, Inc. | 9.12M | 3.23% | 72,394 | - |
| 551 | MBIO | Mustang Bio, Inc. | 9.05M | 6.90% | 96,167 | - |
| 552 | XTLB | XTL Biopharmaceuticals Ltd. | 8.94M | -3.31% | 30,906 | 451.00K |
| 553 | PLRZ | Polyrizon Ltd. | 8.91M | 3.82% | 118,742 | - |
| 554 | BOLT | Bolt Biotherapeutics, Inc. | 8.77M | 1.33% | 33,040 | 5.20M |
| 555 | TOVX | Theriva Biologics, Inc. | 8.43M | 5.31% | 2,214,219 | - |
| 556 | PHGE | BiomX Inc. | 7.67M | -8.66% | 579,783 | - |
| 557 | KPRX | Kiora Pharmaceuticals, Inc. | 7.59M | -0.96% | 105,716 | 20.00K |
| 558 | MTNB | Matinas BioPharma Holdings, Inc. | 7.54M | -0.30% | 2,059 | - |
| 559 | TCRT | Alaunos Therapeutics, Inc. | 7.52M | 4.66% | 79,354 | 6.00K |
| 560 | RNAZ | TransCode Therapeutics, Inc. | 7.52M | -4.14% | 10,201 | - |
| 561 | PHIO | Phio Pharmaceuticals Corp. | 7.50M | -0.76% | 375,703 | - |
| 562 | APRE | Aprea Therapeutics, Inc. | 7.49M | -0.29% | 30,771 | 488.24K |
| 563 | INAB | IN8bio, Inc. | 7.46M | 1.26% | 69,796 | - |
| 564 | ADIL | Adial Pharmaceuticals, Inc. | 7.29M | -2.12% | 421,741 | - |
| 565 | ENSC | Ensysce Biosciences, Inc. | 6.91M | -0.51% | 82,934 | 4.49M |
| 566 | ACXP | Acurx Pharmaceuticals, Inc. | 6.68M | 3.79% | 31,190 | - |
| 567 | PTN | Palatin Technologies, Inc. | 6.33M | 7.57% | 35,900 | 8.85M |
| 568 | NCNA | NuCana plc | 6.18M | 1.25% | 41,382 | - |
| 569 | ENTO | Entero Therapeutics, Inc. | 6.15M | 2.11% | 13,677 | - |
| 570 | GLMD | Galmed Pharmaceuticals Ltd. | 6.14M | 6.67% | 22,858,274 | - |
| 571 | PPBT | Purple Biotech Ltd | 6.11M | 10.07% | 552,839 | - |
| 572 | JAGX | Jaguar Health, Inc. | 6.09M | -9.70% | 135,508 | 11.79M |
| 573 | CLDI | Calidi Biotherapeutics, Inc. | 6.08M | 0.67% | 76,745 | - |
| 574 | LYRA | Lyra Therapeutics, Inc. | 5.99M | -2.68% | 11,798 | 600.00K |
| 575 | VIVS | VivoSim Labs, Inc. | 5.95M | - | 37,878 | 140.00K |
| 576 | XBIO | Xenetic Biosciences, Inc. | 5.86M | 2.68% | 33,320 | 2.86M |
| 577 | CYCN | Cyclerion Therapeutics, Inc. | 5.52M | 4.32% | 38,118 | 2.86M |
| 578 | QLGN | Qualigen Therapeutics, Inc. | 5.51M | 6.91% | 324,694 | - |
| 579 | SILO | Silo Pharma, Inc. | 5.43M | -0.16% | 254,393 | 72.10K |
| 580 | ASBP | Aspire Biopharma Holdings, Inc. | 5.35M | 18.29% | 233,447,156 | 1.94K |
| 581 | HCWB | HCW Biologics Inc. | 5.29M | -19.61% | 130,666 | 422.03K |
| 582 | REVB | Revelation Biosciences, Inc. | 5.15M | -1.46% | 39,856 | - |
| 583 | PBM | Psyence Biomedical Ltd. | 5.15M | -4.84% | 16,232 | - |
| 584 | CDIO | Cardio Diagnostics Holdings, Inc. | 5.15M | -5.75% | 31,898 | 15.78K |
| 585 | PMCB | PharmaCyte Biotech, Inc. | 5.12M | 3.85% | 29,104 | - |
| 586 | SLRX | Salarius Pharmaceuticals, Inc. | 5.04M | -6.43% | 936,772 | - |
| 587 | KTTA | Pasithea Therapeutics Corp. | 4.91M | -9.60% | 299,334 | - |
| 588 | KALA | KALA BIO, Inc. | 4.82M | -1.89% | 148,424 | - |
| 589 | OGEN | Oragenics, Inc. | 4.54M | -1.80% | 16,258 | - |
| 590 | GRI | GRI Bio, Inc. | 4.53M | 12.50% | 76,765 | - |
| 591 | GNPX | Genprex, Inc. | 4.52M | -10.40% | 951,349 | - |
| 592 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 4.23M | 0.98% | 22,236 | 1.36M |
| 593 | PTIX | Protagenic Therapeutics, Inc. | 3.94M | -0.72% | 10,192 | - |
| 594 | BGMS | Bio Green Med Solution, Inc. | 3.91M | 9.92% | 422,523 | 81.00K |
| 595 | SPRC | SciSparc Ltd. | 3.88M | -3.24% | 19,125 | 1.31M |
| 596 | ONCO | Onconetix, Inc. | 3.87M | 7.79% | 53,255 | 1.22M |
| 597 | CNSP | CNS Pharmaceuticals, Inc. | 3.86M | 0.15% | 3,461 | - |
| 598 | ARTL | Artelo Biosciences, Inc. | 3.73M | 1.64% | 35,805 | - |
| 599 | ELAB | PMGC Holdings Inc. | 3.72M | -4.03% | 42,805 | -241.53K |
| 600 | XRTX | XORTX Therapeutics Inc. | 3.22M | 3.23% | 92,638 | - |
| 601 | SCNI | Scinai Immunotherapeutics Ltd. | 3.10M | 1.10% | 51,844 | 1.15M |
| 602 | ENVB | Enveric Biosciences, Inc. | 3.01M | 16.70% | 55,091 | - |
| 603 | BDRX | Biodexa Pharmaceuticals Plc | 2.79M | -17.49% | 129,576 | 104.90K |
| 604 | INDP | Indaptus Therapeutics, Inc. | 2.61M | 3.96% | 24,185 | - |
| 605 | GTBP | GT Biopharma, Inc. | 2.34M | -4.36% | 595,819 | - |
| 606 | MLEC | Moolec Science SA | 2.24M | 0.28% | 29,883 | 7.83M |
| 607 | VRAX | Virax Biolabs Group Limited | 2.05M | -0.25% | 37,914 | 6.33K |
| 608 | DRMA | Dermata Therapeutics, Inc. | 1.84M | -4.93% | 17,325 | - |
| 609 | SLXN | Silexion Therapeutics Corp | 1.45M | -0.15% | 27,691 | - |
| 610 | CMND | Clearmind Medicine Inc. | 1.26M | -16.94% | 76,114,250 | - |
| 611 | AZTR | Azitra, Inc. | 1.19M | -0.06% | 205,625 | 7.50K |
| 612 | CDT | CDT Equity Inc. | 822.92K | -1.90% | 20,478 | - |
| 613 | ADTX | Aditxt, Inc. | 180.12K | -3.54% | 33,762 | 5.95K |